Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,045 USD | +3,45% | -11,76% | -26,83% |
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 176 mln. 164 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -122 mln. -113 mln. | Nettowinst (verlies) 2022 | -115 mln. -107 mln. | EV/omzet 2021 | - |
Nettoliquiditeiten 2021 | 12,15 mln. 11,28 mln. | Nettoschuld 2022 | 3,2 mln. 2,97 mln. | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-2,63
x | K/w-verhouding 2022 |
-1,23
x | Werknemers | 66 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 99,84% |
Recentste transcriptie over Evelo Biosciences, Inc.
1 dag | +3,45% | ||
1 week | -11,76% | ||
Lopende maand | -13,63% | ||
1 maand | -13,46% | ||
3 maanden | -25,00% | ||
6 maanden | -98,88% | ||
Lopend jaar | -26,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | 21/11 |
Andrea Itano
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Duncan McHale
CTO | Chief Tech/Sci/R&D Officer | 57 | 01-02-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | 21/11 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 0,045 | +3,45% | 32 383 |
27-03-24 | 0,0435 | -13,00% | 14 168 |
26-03-24 | 0,05 | 0,00% | 50 314 |
25-03-24 | 0,05 | -17,49% | 48 860 |
22-03-24 | 0,0606 | +18,82% | 10 735 |
uitgestelde koers OTC Markets, 28 maart 2024 om 20:35 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-26,83% | 854K | |
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-35,36% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |